All Articles
Browse the full research library.
Semaglutide for Alcohol Use Disorder: What the VA Trial Means for GLP-1 Weight Loss Patients
The VA trial testing semaglutide for alcohol use disorder could reshape understanding of GLP-1 drugs. This article examines the research, misconceptions
Semaglutide Microdosing: Low-Dose GLP-1 Research
Semaglutide microdosing explores low GLP-1 doses for weight loss, aiming to reduce misuse risks. Research is nascent, with no consensus on efficacy or
AOD-9604 and Tirzepatide Stack: Metabolic Synergy Amid FDA Scrutiny
AOD-9604 and tirzepatide are being studied for their potential metabolic synergy in targeting stubborn fat. This article examines the research, regulatory
Semaglutide vs. Retatrutide: FDA Panel’s Triple-Agonist Shift
The FDA peptide panel is evaluating retatrutide, a triple-agonist, against semaglutide for weight loss. Research shows retatrutide may achieve greater
Semaglutide Safety After Compounding Pharmacy Concerns
MedPage Today's investigation into compounded semaglutide revealed dosing errors and contamination risks. This article examines the research on
AOD-9604 and CJC-1295 Stack: Research on Body Recomposition
Research examines AOD-9604 and CJC-1295 for body recomposition during semaglutide use. Current data on mitigating muscle loss remain limited and